Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
+10.61%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$54.6B
AUM Growth
+$6.32B
(+13%)
Cap. Flow
+$1.51B
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
18.73%
Holding
4,080
New
257
Increased
1,843
Reduced
1,682
Closed
180
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$66.6M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$64.3M |
| 3 |
First Trust Rising Dividend Achievers ETF
RDVY
|
+$48.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$41.8M |
| 5 |
Capital Group Growth ETF
CGGR
|
+$37.3M |
Top Sells
Sector Composition
| 1 | Technology | 11.61% |
| 2 | Financials | 5.39% |
| 3 | Consumer Discretionary | 4.27% |
| 4 | Healthcare | 4.16% |
| 5 | Industrials | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Zevia
ZVIA
$184M
| $27K | ﹤0.01% |
13,539
-32,373
| -71% | -$64.6K |
|
|
EMX
3802
EMX Royalty
EMX
$448M
| $26K | ﹤0.01% |
16,019
| – | – |
|
|
TGB
3803
Taseko Mines
TGB
$1.07B
| $26K | ﹤0.01% |
18,695
| – | – |
|
3804
Genprex
GNPX
$6.99M
| $25K | ﹤0.01% |
+2,683
| New | +$25K |
|
3805
Akebia Therapeutics
AKBA
$795M
| $23K | ﹤0.01% |
+18,736
| New | +$23K |
|
3806
Pyxis Oncology
PYXS
$113M
| $23K | ﹤0.01% |
12,950
| – | – |
|
|
RGLS
3807
DELISTED
Regulus Therapeutics
RGLS
| $22K | ﹤0.01% |
17,500
| – | – |
|
|
LICY
3808
DELISTED
Li-Cycle Holdings Corp.
LICY
| $22K | ﹤0.01% |
4,748
-5,849
| -55% | -$27.1K |
|
3809
X4 Pharmaceuticals
XFOR
$73.6M
| $21K | ﹤0.01% |
837
-55
| -6% | -$1.38K |
|
3810
Pixelworks
PXLW
$62.5M
| $20K | ﹤0.01% |
1,300
| – | – |
|
3811
Rigel Pharmaceuticals
RIGL
$644M
| $20K | ﹤0.01% |
+1,349
| New | +$20K |
|
|
MJUS
3812
DELISTED
Amplify U.S. Alternative Harvest ETF
MJUS
| $20K | ﹤0.01% |
12,322
-10,868
| -47% | -$17.6K |
|
3813
Apollomics
APLM
$5.99M
| $19K | ﹤0.01% |
+200
| New | +$19K |
|
|
BLUE
3814
DELISTED
bluebird bio
BLUE
| $19K | ﹤0.01% |
+705
| New | +$19K |
|
|
CIF
3815
MFS Intermediate High Income Fund
CIF
$31.7M
| $19K | ﹤0.01% |
10,854
-13,925
| -56% | -$24.4K |
|
3816
Clene
CLNN
$66.2M
| $19K | ﹤0.01% |
+3,158
| New | +$19K |
|
3817
Gevo
GEVO
$389M
| $19K | ﹤0.01% |
16,296
-2,240
| -12% | -$2.61K |
|
3818
Origin Materials
ORGN
$78.5M
| $19K | ﹤0.01% |
22,634
+8,500
| +60% | +$7.14K |
|
3819
ESS Tech
GWH
$19.5M
| $18K | ﹤0.01% |
1,053
+171
| +19% | +$2.92K |
|
3820
BioCardia
BCDA
$12.2M
| $17K | ﹤0.01% |
1,733
+1,060
| +158% | +$10.4K |
|
3821
Perspective Therapeutics
CATX
$255M
| $17K | ﹤0.01% |
4,228
| – | – |
|
|
DBVT
3822
DBV Technologies
DBVT
$238M
| $17K | ﹤0.01% |
1,788
+118
| +7% | +$1.12K |
|
3823
Sangamo Therapeutics
SGMO
$157M
| $17K | ﹤0.01% |
31,648
-18,648
| -37% | -$10K |
|
|
FRZA
3824
DELISTED
Forza X1, Inc. Common Stock
FRZA
| $17K | ﹤0.01% |
31,500
+12,500
| +66% | +$6.75K |
|
3825
Aqua Metals
AQMS
$5.09M
| $16K | ﹤0.01% |
107
| – | – |
|